Trading Update

Advanced Medical Solutions Grp PLC
14 December 2005


For immediate release                                           14 December 2005


                      Advanced Medical Solutions Group plc
                            ('AMS' or 'the Company')

                                 Trading Update


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
woundcare technology company, today announces an update on current trading.

Dr. Geoffrey Vernon, Chairman of Advanced Medical Solutions Group plc, stated:

'I am pleased to say that the progress reported at the half-year has continued
during the second half and, as we move into the close period for the year ending
31 December 2005, the Company continues to trade in line with market
expectations.'



                                     -ENDS-



For further information, please contact:

Advanced Medical Solutions Group plc                   Tel: [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                                Tel: [phone]
Mark Court, Mary-Jane Johnson



Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $13 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.

AMS's technology and products currently serve the majority of the key global
markets and strategic partners.


                      This information is provided by RNS
            The company news service from the London Stock Exchange